Next Science Says Complaint Filed by Ex-Employee Dismissed by Court; Shares Up 4%

MT Newswires Live

May 05, 2025

Next Science (ASX:NXS) said the derivative complaint filed by former employee Michael Morello in Florida's Duval County Court has been dismissed for lack of standing, according to a Monday filing with the Australian bourse.

The complaint alleges that the company's Xbio technology has not been approved by the US Food and Drug Administration for biofilm eradication and that the company failed to address safety concerns regarding its Xperience surgical solution in breast implant procedures, the company said in a Jan. 8 filing.

The litigation initiated by the company against Morello and other former employees for breach of post-employment restraints is underway.

Next Science's shares rose more than 4% in midday trade Monday.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2533373229"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2533373229\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2533373229?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-05-05 11:23","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2533373229","market":"hk","top_or_hot":-1,"title":"Next Science Says Complaint Filed by Ex-Employee Dismissed by Court; Shares Up 4%","media":"MT Newswires Live","content":"<html><body><p> Next Science (ASX:NXS) said the derivative complaint filed by former employee Michael Morello in Florida's Duval County Court has been dismissed for lack of standing, according to a Monday filing with the Australian bourse.</p><p>The complaint alleges that the company's Xbio technology has not been approved by the US Food and Drug Administration for biofilm eradication and that the company failed to address safety concerns regarding its Xperience surgical solution in breast implant procedures, the company said in a Jan. 8 filing.</p><p>The litigation initiated by the company against Morello and other former employees for breach of post-employment restraints is underway.</p><p>Next Science's shares rose more than 4% in midday trade Monday.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Next Science Says Complaint Filed by Ex-Employee Dismissed by Court; Shares Up 4%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNext Science Says Complaint Filed by Ex-Employee Dismissed by Court; Shares Up 4%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-05-05 11:23</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Next Science (ASX:NXS) said the derivative complaint filed by former employee Michael Morello in Florida's Duval County Court has been dismissed for lack of standing, according to a Monday filing with the Australian bourse.</p><p>The complaint alleges that the company's Xbio technology has not been approved by the US Food and Drug Administration for biofilm eradication and that the company failed to address safety concerns regarding its Xperience surgical solution in breast implant procedures, the company said in a Jan. 8 filing.</p><p>The litigation initiated by the company against Morello and other former employees for breach of post-employment restraints is underway.</p><p>Next Science's shares rose more than 4% in midday trade Monday.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK7126","symbol_name":"医疗保健用品","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2533373229","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2533373229","pubTimestamp":1746415391,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Next Science  said the derivative complaint filed by former employee Michael Morello in Florida's Duval County Court has been dismissed for lack of standing, according to a Monday filing with the Australian bourse.The complaint alleges that the company's Xbio technology has not been approved by the US Food and Drug Administration for biofilm eradication and that the company failed to address safety concerns regarding its Xperience surgical solution in breast implant procedures, the company said in a Jan. 8 filing.The litigation initiated by the company against Morello and other former employees for breach of post-employment restraints is underway.Next Science's shares rose more than 4% in midday trade Monday.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK7126":"医疗保健用品","NXS.AU":"NEXT SCIENCE LTD"},"translate_title":"Next Science称前雇员提出的申诉被法院驳回；股价上涨4%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NXS.AU":0.9},"content_text":"Next Science (ASX:NXS) said the derivative complaint filed by former employee Michael Morello in Florida's Duval County Court has been dismissed for lack of standing, according to a Monday filing with the Australian bourse.The complaint alleges that the company's Xbio technology has not been approved by the US Food and Drug Administration for biofilm eradication and that the company failed to address safety concerns regarding its Xperience surgical solution in breast implant procedures, the company said in a Jan. 8 filing.The litigation initiated by the company against Morello and other former employees for breach of post-employment restraints is underway.Next Science's shares rose more than 4% in midday trade Monday.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}